《新股消息》京东健康(06618.HK)孖展额增至近1,100亿元 超购逾80倍
京东健康(06618.HK)次日招股,截至下午约6时,本地券商为其借出近1,100亿元孖展额,以公开发售部分集资约13.47亿元计算,超额认购约80.5倍。
京东健康的招股期将於下周二(12月1日)结束,预期12月8日挂牌上市。今日有市场消息指,由於认购反应热烈,国际配售部分将提早在下周一(30日)下午5时截止认购。
另外,华润置地(01109.HK)旗下华润万象生活(01209.HK)招股期踏入第三天,券商数据显示暂录孖展认购约27亿元,以其公开发售部分集资6.13亿元计超购近3.5倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.